Latest Uk Market News

TechnologyOne Limited has reported a robust first half for FY25, with annual recurring revenue exceeding $500 million well ahead of schedule and profit before tax climbing 33%. The company’s SaaS+ platform and strategic acquisition of CourseLoop are driving growth and positioning it for ambitious long-term targets.

TechnologyOne has reported record half-year results, boosting full-year profit growth guidance to 13%–17%, driven by its pioneering SaaS+ ERP platform and strategic expansion.

Technology One Limited has reported a record half-year performance, with revenue up 19% and net profit after tax rising 31%, driven by strong SaaS growth and strategic acquisitions.

ECS Botanics is on track for a record-breaking FY25 harvest with a 50% production increase and new premium product launches, signaling strong growth and a positive cash flow outlook.

Xero Limited reported a robust FY25 with 23% revenue growth and a 22% rise in adjusted EBITDA, underpinned by subscriber and ARPU gains across key markets. The company is doubling down on AI integration and disciplined capital allocation to sustain momentum.

Lendlease is in advanced talks to form a 50/50 joint venture with Crown Estate, aiming to accelerate capital release and enhance development delivery across its UK portfolio.

PEXA Group’s third-quarter results align with expectations, driven by Australian growth and UK market headwinds. The company reaffirms its FY25 guidance while navigating ongoing business assessments and regulatory milestones.

IODM Limited reported a solid Q3 FY25 with cash receipts up 18%, driven by strong UK Education segment growth and new revenue share agreements in North America.

PEXA has achieved a crucial regulatory milestone with FCA approval to operate as an Authorised Payment Institution in the UK, paving the way for its Sale & Purchase product launch later this year.

Beonic Limited reported a 6.5% increase in annual recurring revenue to $17.8 million and a significant gross margin improvement to 75.5%, driven by new global contracts and disciplined cost management. The company targets cash flow breakeven in Q4 FY25 and an EBITDA margin of up to 15%.

Microba Life Sciences reported robust Q3 FY25 growth in its microbiome diagnostic tests, led by MetaXplore and MetaPanel, while advancing its therapeutics pipeline and projecting strong full-year revenue growth.

Pureprofile Limited reported a robust 16% revenue increase in Q3 FY25, driven by strong international expansion and new AI-powered solutions, while reaffirming its FY25 financial guidance.